Chlamydia trachomatis and Neisseria gonorrhoeae by Transcription-Mediated Amplification (TMA), M4/UTM
Ordering Recommendation
Viral transport media (eg, M4/UTM) is not preferred when testing for Chlamydia trachomatis and Neisseria gonorrhoeae by transcription-mediated amplification (TMA). The preferred test is Chlamydia trachomatis and Neisseria gonorrhoeae by Transcription-Mediated Amplification (TMA).
Transcription-Mediated Amplification
1-2 days  
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
Specimen Required
Patient Preparation
Endocervical or urethral swab in viral transport media (M4) or UTM (ARUP supply #12884). Available online through eSupply using ARUP Connect™ or contact ARUP Client Services at (800) 522-2787. Refer to "Sample Collection for the Diagnosis of STD" under Specimen Handling at for specific specimen collection and transport instructions.  
Specimen Preparation
Transport swab in 3 mL viral transport media (M4 or UTM). (Min: 1 mL)  
Storage/Transport Temperature
Unacceptable Conditions
Specimens in any transport media other than indicated above. Specimens from patients that are less than 16 years of age.  
Specimen source required.  
Ambient: 1 week; Refrigerated: 1 month; Frozen: 3 months  
Reference Interval
Test Number Components Reference Interval
0060243Chlamydia trachomatis by Transcription-​Mediated Amplification (TMA) Negative
0060244Neisseria gonorrhoeae by Transcription-​Mediated Amplification (TMA) Negative
Interpretive Data
Use of transport media other than the manufacturer's collection kit (eg, viral transport media) may result in reduced sensitivity. Specimens should be collected and transported following the instructions in "Sample Collection for the Diagnosis of STD Using Nucleic Acid Amplification Tests" under Specimen Handling at

Positive results are confirmed using an alternative nucleic acid target in accordance with CDC guidelines. See: Screening Tests To Detect Chlamydia trachomatis and Neisseria gonorrhoeae Infections-2002. (

This test is intended for medical purposes only and is not valid for the evaluation of suspected sexual abuse or for other forensic purposes.
In certain contexts, culture may be required to meet applicable laws and regulations for diagnosis of C. trachomatis and N. gonorrhoeae infections.

See Compliance Statement B:
Statement B: This test was developed and its performance characteristics determined by ARUP Laboratories. The U.S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
The performance of this test has not been evaluated in adolescents less than 16 years of age.
CPT Code(s)
87491; 87591
Component Test Code*Component Chart Name
0060775C. trachomatis by TMA, M4/UTM
0060776N. gonorrhoeae by TMA, M4/UTM
0060777Specimen Source
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
  • Chlamydia and GC TMA panel
  • CT/GC M4/UTM
  • Gonorrhea UTM
  • Nucleic Acid Amplification Test (NAAT)